Microsoft AI CEO Mustafa Suleyman said medicine represents artificial intelligence's largest commercial opportunity, predicting that access to expert-level medical guidance will become available for roughly $20 per month. His comments come as health-related queries already account for 40% of weekly interactions with Microsoft's AI tools, with millions of people using them daily for medical information.
Suleyman, who co-founded DeepMind before joining Microsoft, argued that the technology's ability to deliver specialist knowledge at a fraction of today's cost positions healthcare as the sector where AI will have its most profound impact. "I think by far the most exciting new market is medicine," he said.
The quality gap that AI could narrow
Suleyman pointed to the vast disparities in medical expertise available to patients as a problem AI is well-suited to address. Even within wealthy nations, the difference in care quality between top-tier specialists and the average patient experience remains stark.
"The quality difference between the top 10 per cent and the bottom 10 per cent, even in the United States, let alone the rest of the world, is unbelievable. The gulf is probably an order of magnitude," he said. AI systems capable of delivering medical superintelligence to anyone with an internet connection could shrink that gap, making expert judgment accessible across regions and income levels.
Millions are already turning to AI for health advice
Healthcare has quietly become one of the dominant use cases for conversational AI. "About 40% of our queries each week are health related. Millions of people a day are asking health related queries," Suleyman said. The volume reflects rising public comfort with using AI assistants to understand symptoms, research conditions, and explore treatment options before-or alongside-consulting a clinician.
To improve reliability, Microsoft grounds its AI responses in trusted medical sources. "We ground the answers in citations from Harvard Medical, the most respected health institution," Suleyman said, emphasizing evidence-based outputs over generic information. This sourcing approach matters particularly in healthcare, where inaccurate guidance carries serious consequences.
AI as a clinical tool, not a replacement
Suleyman's vision positions AI as a complement to physicians rather than a substitute. The tools can help patients prepare for consultations, understand complex medical information, and access reliable guidance between appointments. Across the industry, technology companies are investing in healthcare applications that range from clinical documentation and diagnostic support to personalized health assistants.
Regulatory oversight and clinical validation remain prerequisites before AI can assume a larger role in medical decision-making. For healthcare organizations evaluating AI for Healthcare tools, understanding where these systems fit into clinical workflows-and where they do not-is becoming a core competency.
Why this matters for healthcare professionals
The 40% figure is the number to pay attention to. Patients are already using AI for health information at scale, whether clinicians are aware of it or not. That means patients are arriving at appointments with AI-generated context about their symptoms and conditions-some of it reliable, some of it not. Knowing which sources patients are consulting, and being prepared to address AI-driven questions directly, is no longer a future concern. It is a current reality that changes the dynamic of the exam room.
Your membership also unlocks:
